| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8696 |
| Human Intestinal Absorption | HIA+ | 0.9789 |
| Caco-2 Permeability | Caco2- | 0.6686 |
| P-glycoprotein Substrate | Non-substrate | 0.8196 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9880 |
| Non-inhibitor | 0.9917 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9500 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8053 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8097 |
| CYP450 2D6 Substrate | Non-substrate | 0.9152 |
| CYP450 3A4 Substrate | Non-substrate | 0.8313 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9490 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9242 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9650 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9621 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9751 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9885 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9794 |
| Non-inhibitor | 0.9841 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.5447 |
| Fish Toxicity | High FHMT | 0.7424 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9191 |
| Honey Bee Toxicity | High HBT | 0.7771 |
| Biodegradation | Ready biodegradable | 0.7842 |
| Acute Oral Toxicity | III | 0.3708 |
| Carcinogenicity (Three-class) | Non-required | 0.7131 |